AAAAAA
Results: 501-525/15678
Authors:
Richman, DD
Citation: Dd. Richman, The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B, HEPATOLOGY, 32(4), 2000, pp. 866-867
Authors:
Manns, MP
Bahr, MJ
Citation: Mp. Manns et Mj. Bahr, Recurrent autoimmune hepatitis after liver transplantation - When non-selfbecomes self, HEPATOLOGY, 32(4), 2000, pp. 868-870
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Medical treatment for primary sclerosing cholangitis: Risk versus benefit, HEPATOLOGY, 32(4), 2000, pp. 871-872
Authors:
Jacobs, RJ
Koff, RS
Citation: Rj. Jacobs et Rs. Koff, Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C, HEPATOLOGY, 32(4), 2000, pp. 873-874
Authors:
Aycock, R
Citation: R. Aycock, Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C, HEPATOLOGY, 32(4), 2000, pp. 873-873
Authors:
Myers, RP
Gregor, JC
Marotta, PJ
Citation: Rp. Myers et al., Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C - Reply, HEPATOLOGY, 32(4), 2000, pp. 874-875
Authors:
Roncalli, M
Borzio, M
Bianchi, P
Laghi, L
Citation: M. Roncalli et al., Comprehensive allelotype study of hepatocellular carcinoma, HEPATOLOGY, 32(4), 2000, pp. 876-876
Authors:
Okabe, H
Ikai, I
Matsuo, K
Satoh, S
Yamaoka, Y
Citation: H. Okabe et al., Comprehensive allelotype study of hepatocellular carcinoma - Reply, HEPATOLOGY, 32(4), 2000, pp. 876-876
Authors:
Hoshida, Y
Shiratori, Y
Omata, M
Citation: Y. Hoshida et al., Difficulties in conducting controlled trials in radical therapies for nonadvanced hepatocellular carcinoma, HEPATOLOGY, 32(4), 2000, pp. 877-880
Authors:
Castilla-Higuero, L
Romero-Gomez, M
Suarez, E
Castro, M
Citation: L. Castilla-higuero et al., Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson's disease, HEPATOLOGY, 32(4), 2000, pp. 877-877
Authors:
Chazouilleres, O
Robert, A
Citation: O. Chazouilleres et A. Robert, Normalizing the prothrombin time, HEPATOLOGY, 32(4), 2000, pp. 881-881
Authors:
Malinchoc, M
Kamath, PS
Citation: M. Malinchoc et Ps. Kamath, Normalizing the prothrombin time - Reply, HEPATOLOGY, 32(4), 2000, pp. 881-881
Authors:
Kramer
Citation: Kramer, Partial pressure of ammonia versus ammonia in hepatic encephalopathy (vol 31, pg 30, 2000), HEPATOLOGY, 32(4), 2000, pp. 882-882
Authors:
Shiesh, SC
Chen, CY
Lin, XZ
Liu, ZA
Tsao, HC
Citation: Sc. Shiesh et al., Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs, HEPATOLOGY, 32(3), 2000, pp. 455-460
Authors:
Lo, GH
Lai, KH
Cheng, JS
Chen, MH
Huang, HC
Hsu, PI
Lin, CK
Citation: Gh. Lo et al., Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: A prospective, randomized trial, HEPATOLOGY, 32(3), 2000, pp. 461-465
Authors:
Condat, B
Pessione, F
Denninger, MH
Hillaire, S
Valla, D
Citation: B. Condat et al., Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy, HEPATOLOGY, 32(3), 2000, pp. 466-470
Authors:
Escorsell, A
Del Arbol, LR
Planas, R
Albillos, A
Banares, R
Cales, P
Pateron, D
Bernard, B
Vinel, JP
Bosch, J
Citation: A. Escorsell et al., Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: The TEST study, HEPATOLOGY, 32(3), 2000, pp. 471-476
Authors:
Cadranel, JF
Rufat, P
Degos, F
Citation: Jf. Cadranel et al., Practices of liver biopsy in France: Results of a prospective nationwide survey, HEPATOLOGY, 32(3), 2000, pp. 477-481
Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines
Authors:
Yamanaka, T
Shiraki, K
Sugimoto, K
Ito, T
Fujikawa, K
Ito, M
Takase, K
Moriyama, M
Nakano, T
Suzuki, A
Citation: T. Yamanaka et al., Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines, HEPATOLOGY, 32(3), 2000, pp. 482-490
Authors:
Nagao, M
Nakajima, Y
Kanehiro, H
Hisanaga, M
Aomatsu, Y
Ko, S
Tatekawa, Y
Ikeda, N
Kanokogi, H
Urizono, Y
Kobayashi, T
Shibaji, T
Kanamura, T
Ogawa, S
Nakano, H
Citation: M. Nagao et al., The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma, HEPATOLOGY, 32(3), 2000, pp. 491-500
Authors:
Moennikes, O
Buchmann, A
Willecke, K
Traub, O
Schwarz, M
Citation: O. Moennikes et al., Hepatocarcinogenesis in female mice with mosaic expression of connexin32, HEPATOLOGY, 32(3), 2000, pp. 501-506
Authors:
Terabe, M
Shimizu, M
Mabuchi, A
Matui, S
Morikawa, H
Kaneda, K
Kakiuchi, T
Yokomuro, K
Citation: M. Terabe et al., Unresponsiveness of intrahepatic lymphocytes to bacterial superantigen: Rapid development of suppressive Mac-1(high) cells in the mouse liver, HEPATOLOGY, 32(3), 2000, pp. 507-513
Authors:
Wustefeld, T
Rakemann, T
Kubicka, S
Manns, MP
Trautwein, C
Citation: T. Wustefeld et al., Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice, HEPATOLOGY, 32(3), 2000, pp. 514-522
Authors:
Tanaka, S
Sugimachi, K
Shirabe, K
Shimada, M
Wands, JR
Sugimachi, K
Citation: S. Tanaka et al., Expression and antitumor effects of TRAIL in human cholangiocarcinoma, HEPATOLOGY, 32(3), 2000, pp. 523-527
Authors:
Fabregat, I
Herrera, B
Fernandez, M
Alvarez, AM
Sanchez, A
Roncero, C
Ventura, JJ
Valverde, AM
Benito, M
Citation: I. Fabregat et al., Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor beta in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway, HEPATOLOGY, 32(3), 2000, pp. 528-535